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Introduction {#sec001}
============

*Vibrio* comprises at least 89 species with validly published names \[[@pone.0144465.ref001]\]. It is one of the most common bacterial groups in marine environments \[[@pone.0144465.ref001],[@pone.0144465.ref002]\]. Although *Vibrio* spp. are of great importance for the remineralization of organic matter in the sea \[[@pone.0144465.ref003]\], the foremost attention brought to this genus is related to its many pathogenic strains. Until now, at least 12 *Vibrio* species have been reported to be pathogenic to human beings \[[@pone.0144465.ref004]\], among which *V*. *cholerae*, *V*. *parahaemolyticus* and *V*. *vulnificus* are the most notorious due to their significant threat to human health and seafood safety \[[@pone.0144465.ref004]--[@pone.0144465.ref006]\]. Some members of *Vibrio* are also causative pathogens for aquatic animals, which often cause enormous economic loss \[[@pone.0144465.ref007]--[@pone.0144465.ref009]\]. In contrast, some species such as *V*. *alginolyticus* have even been reported as probiotics for shrimp aquaculture \[[@pone.0144465.ref010],[@pone.0144465.ref011]\].

Despite that *Vibrio* spp. has a significant impact on the health of humankind and aquatic animals, the molecular basis of their pathogenesis is little known, mainly due to the limited genetic tools available for the functional research of genes in most pathogenic *Vibrio* species \[[@pone.0144465.ref012]\]. Generally, gene deletion coupled with its complementation is one direct way to assess the function of a gene of interest. One of the most widely used methods is allelic exchange between a target gene and a mutation fragment carried by a suicide vector (plasmid) harboring an antibiotic-resistant cassette and a counterselectable gene \[[@pone.0144465.ref013]\]. In this way, a suicide vector is driven into recipient cells through conjugation. Under selective stress from an antibiotic environment, recipient cells and the plasmid cannot survive unless the plasmid integrates into a specific site through homologous recombination \[[@pone.0144465.ref014]\]. As allelic exchange mutants may represent only a small fraction of the transformants and may be difficult to isolate, a counterselectable marker is often instrumental for the acquisition of a deletion mutant \[[@pone.0144465.ref013],[@pone.0144465.ref014]\]. In the presence of the counterselective compound, a counterselectable gene promotes the death of the microorganisms harboring this gene, and only the deletion mutant losing the integrated form of the vector through a second homologous recombination and the resultant wild-type clones can survive \[[@pone.0144465.ref014],[@pone.0144465.ref015]\].

The *Bacillus subtilis* levansucrase gene *sacB* is now certainly the most commonly used of the different counterselectable markers due to its general efficiency in Gram-negative bacteria and for the simplicity of the counterselection protocol \[[@pone.0144465.ref012],[@pone.0144465.ref016]\]. *sacB*-based suicide vectors have been occasionally used for allelic exchange in several *Vibrio* species, such as *V*. *cholerae* \[[@pone.0144465.ref016],[@pone.0144465.ref017]\], *V*. *anguillarum* \[[@pone.0144465.ref018]\], and *V*. *alginolyticus* \[[@pone.0144465.ref019]\]. However, the use of this gene for allelic exchange in more *Vibrio* species or in other common bacterial species is seriously impeded by the necessary absence of NaCl in the counterselection medium \[[@pone.0144465.ref012]\]. Milton et al. reported that although they obtained a null *flaA* mutant of *V*. *anguillarum* through the use of a *sacB*-based suicide vector, pDM4, *sacB* did not work well, as both colonies lacking the *flaA* gene and colonies maintaining the integrated vector occurred on sucrose-containing plates \[[@pone.0144465.ref018]\]. In another case of a deletion mutation in *V*. *vulnificus* by using a *sacB*-based suicide vector, counterselection of sucrose sensitivity was not very efficient, as it was time-consuming and involved the screening of large numbers of colonies to find truly sucrose-resistant colonies \[[@pone.0144465.ref020]\]. In our laboratory, *sacB-*based pDM4 was also used for a deletion mutation in *V*. *alginolyticus* \[[@pone.0144465.ref019]\], but it is troublesome to arduously screen deletion mutants from numerous background false-positive colonies (internal communication). These cases strongly support the idea that *sacB* is not an ideal counterselectable marker for allelic exchange in halophilic *Vibrio*. Therefore, it is necessary to explore new counterselectable markers for genetic manipulation in *Vibrio*.

In 2005, Demarre et al. developed a series of pSW suicide plasmids and their cognate *E*. *coli* host strains. These plasmids have small sizes (without *mob* genes) and lack identity with any bacterial chromosome gene \[[@pone.0144465.ref021]\], which apparently enhances the transfer efficiency of the plasmids and largely reduces incorrect integration. Δ*dapA* and Δ*thyA E*. *coli* strains facilitate the counterselection if they are used in plasmid transfer experiments into markerless recipients \[[@pone.0144465.ref021]\]. Demarre et al. also verified the high conjugation--recombination frequency when this recombineering system was applied to allelic replacement of *V*. *cholerae* \[[@pone.0144465.ref021]\]. However, all of these plasmids lack the second necessary counterselectable markers, which limit their further application in complete gene knockout in *Vibrio*.

In the present study, we discovered that two uncharacterized genes, *vmi480* (VMD_06480) and *vmi470* (VMD_06470), in a *V*. *mimicus* strain VM573 (NZ_ACYV01000005) formed a new toxin-antitoxin (TA) system. The toxin gene *vmi480* was introduced into a suicide plasmid constructed from pSW23T and pSW25T-*ccdB*. Finally, we obtained two novel suicide T-Vectors, pLP11 and pLP12, carrying the *vmi480* gene as a counterselectable marker. Through the use of pLP11 and pLP12 coupled with a high-efficiency conjugation system provided by host strain *E*. *coli* β2163, we easily deleted six genes in *V*. *alginolyticus*, *V*. *cholerae*, *V*. *parahaemolyticus*, and *V*. *vulnificus*. Therefore, our results demonstrated that we successfully developed universal genetic tools for a rapid and efficient deletion mutation in *Vibrio* species.

Results {#sec002}
=======

Functional Prediction of *vmi480* and *vmi470* {#sec003}
----------------------------------------------

Previously, we obtained an *E*. *coli* strain LP79 harboring a genomic island, MGI*Vmi*1, from *V*. *mimicus* VM573 through conjugation \[[@pone.0144465.ref022]\]. MGI*Vmi*1 includes two adjacent genes, *vmi480* and *vmi470*, on the same strand. There is a 5-bp short intergenic region separating two genes, while the genes flanking *vmi480* and *vmi470* are located on the opposite strand and maintain 600-bp and 73-bp intervals from the *vmi480*-*vmi470* locus. There is an intact promoter region upstream of *vmi480* ([Fig 1A](#pone.0144465.g001){ref-type="fig"}). These features indicated that *vmi480* and *vmi470* belonged to the same transcriptional unit and were likely functionally related. Blastx searches revealed that *vmi470* encoded a DNA-binding protein; however, conserved domain analysis showed that the product of *vmi470* had a Zn-dependent peptidase domain at the C-terminal region besides a DNA-binding helix-turn-helix domain at the N-terminal region ([Fig 1B](#pone.0144465.g001){ref-type="fig"}). Blastx searches also revealed that *vmi480* coded for a hypothetical protein with unknown function and that genes similar to them could only be found in *V*. *mimicus* SX-4, *V*. *anguillarum* 775, a strain from *V*. *cholerae* and a strain from *V*. *ordalii*. In spite of the lack of similarity between two genes and reported toxin-antitoxin genes, the genetic configuration in which *vmi480* and *vmi470* are tightly linked in an operon resemble the findings observed for most type II toxin-antitoxin (TA) systems \[[@pone.0144465.ref023],[@pone.0144465.ref024]\]. Then web-based TA prediction was carried on *vmi480* and *vmi470*. The result showed that *vmi480* failed to match any identified toxin genes in database through conserved domain analysis; however the product of *vmi470* contains a DNA-binding helix-turn-helix domain shared by several antitoxins.

![Features of *vmi480* and *vmi470*.\
**(a)** Schematic diagram of a potential toxin-antitoxin system comprising *vmi480* and *vmi470*. *vmi480* and *vmi470* are located on the same strand and are separated from flanking genes, *mobI* and *res2*. There is a 5-bp intergenic region between *vmi480* and *vmi470*. Upstream of *vmi480*, there is a promoter region for *vmi480* and *vmi470*. These features suggest that *vmi480* and *vmi470* belong to one transcriptional unit and that they are functionally related. The bending arrow represents the position of the promoter, and the white letters on the black background represent the -10 and-35 regions of the promoter. **(b)** Conserved domain analysis of Vmi470. At the N-terminal of Vmi470, there is a DNA-binding helix-turn-helix domain, and at the C-terminal of Vmi470, there is a Zn-dependent peptidase domain.](pone.0144465.g001){#pone.0144465.g001}

*vmi480* and *vmi470* Constitute a Toxin-Antitoxin Module {#sec004}
---------------------------------------------------------

To further explore the functions of *vmi480* and *vmi470*, we attempted to delete them in *E*. *coli* through one-step inactivation based on the λ recombination system \[[@pone.0144465.ref025]\]. We easily deleted *vmi480* or both genes but we failed to solely delete *vmi470* in three attempts, which suggest that retaining *vmi480* without *vmi470* may be poisonous to the cells. It raised a concern that *vmi480* and *vmi470* may form a TA pair. *vmi470*, *vmi480* or both genes were further cloned into the expression vector pBAD30. Transformants of *E*. *coli* NEB 5α hosting pBAD30-*vmi480*-*470* (LP134) and pBAD30-*vmi470* (LP135) were easily constructed. In the case of the strain LP134, co-expression of *vmi480* and *vmi470* under the control of P~BAD~ promoter can be achieved as they locate on the same transcription unit. However, a transformant of *E*. *coli* NEB 5α hosting pBAD30-*vmi480* could not be constructed in the initial attempts. This transformant (LP192) was finally constructed by using Luria-Bertani (LB) plates supplemented with D-glucose that blocked the basic expression of *vmi480*. The results showed that basic expression of *vmi480* probably caused some stress on recovered cells, which prevented the formation of the transformant. When blocked by D-glucose or induced by L-arabinose, LP134 (pBAD30-*vmi480*-*470*) and LP135 (pBAD30-*vmi470*) grew well, and no differences were observed between block and induction treatment ([Fig 2](#pone.0144465.g002){ref-type="fig"}). When blocked by D-glucose, LP192 (pBAD30-*vmi480*) grew well, but when inactivated by L-arabinose, LP192 did not grow, as no clones were discovered ([Fig 2](#pone.0144465.g002){ref-type="fig"}).These results indicated that sole expression of *vmi480* is lethal to the cells but the lethal effect can be eliminated when *vmi480* and *vmi470* are co-expressed in the same vector. It demonstrated that Vmi480 serves as a type of toxin that has a strong lethal effect, while Vmi470 is the antidote of Vmi480. Coupled with the above genetic analysis, the success of deleting *vmi480* or *vmi480*-*vmi470*, and the failure of deleting *vmi470*, these results demonstrate that *vmi480* and *vmi470* compose a two component TA module. An outline of these evidences was shown in [Table 1](#pone.0144465.t001){ref-type="table"}. The strong lethality of *vmi480* product establishes a foundation for applying it as a counterselective marker.

![The effect of the expression of *vmi480* and *vmi470* on the growth of *E*. *coli* cells.\
a, b, c: expression of *vmi480*-*470* (LP134), *vmi470* (LP135), and *vmi480* (LP192) were blocked by D-glucose (0.3%), respectively. d, e, f: expression of *vmi480*-*470* (LP134), *vmi470* (LP135), and *vmi480* (LP192) were activated by L-arabinose (0.2%), respectively.](pone.0144465.g002){#pone.0144465.g002}

10.1371/journal.pone.0144465.t001

###### An outline of evidences that *vmi480* and *vmi470* constitute a TA module.

![](pone.0144465.t001){#pone.0144465.t001g}

  Aspects                  Evidences
  ------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------
  **Genetic analysis**     1\. *vmi480* and *vmi470* constitute an operon with their own promoter and their genetic configuration resemble those of most type II TA systems.
                           2\. *vmi470* contains a DNA-binding helix-turn-helix domain shared by several antitoxins.
  **Deletion mutants**     3\. Deletion of *vmi480* or *vmi480*-*vmi470* can be achieved while deletion of sole *vmi470* cannot fulfill.
  **Ectopic expression**   4\. Sole expression of *vmi480* is lethal to the cells.
                           5\. Sole expression of *vmi470* has no effect on cell growth.
                           6\. Lethality of Vmi480 can be eliminated when both genes are co-expressed in one vector.

Suicide T-Vectors pLP11-T and pLP12-T for Gene Disruption in *Vibrio* {#sec005}
---------------------------------------------------------------------

As shown in [Fig 3](#pone.0144465.g003){ref-type="fig"}, we first constructed a derivative plasmid pLP10. pLP10 consists of a fragment containing an R6K origin of replication (*oriV* ~R6Kγ~), an RP4 origin of transfer (*oriT* ~RP4~) and a chloramphenicol-resistant gene (*cat*) from pSW23T, and a fragment containing a lethal counterselectable gene *ccdB* and a P~TAC~ promoter system from pSW25T-*ccdB*. A multiple cloning site (MCS, *Ahd*I-*Eco*RI-*Sac*I-*Ahd*I-*Nhe*I) was introduced into pLP10 by primers pSW23T-F and pSW25T-F. The *ccdB* gene in pLP10 was replaced by *vmi480* to generate a plasmid pLP11, and then, the P~TAC~ promoter system in pLP11 was replaced by the P~BAD~ promoter system to generate a new plasmid, pLP12. Therefore, the only difference between pLP11 and pLP12 is that the expression of *vmi480* is controlled by the P~TAC~ promoter (pLP11) or by the P~BAD~ promoter (pLP12). Suicide T-vectors, pLP11-T and pLP12-T, were obtained by the amplification of pLP11 and pLP12 following *Ahd*I digestion, which led to each T-vector having single base 3\'-T overhangs on both ends. Thus, the overlap of the PCR products of target genes can be purified and directly ligated into linearized pLP11-T or pLP12-T through common TA cloning without digestion steps of overlap PCR products.

![Schematic diagram of the construction of suicide plasmids pLP11 and pLP12.](pone.0144465.g003){#pone.0144465.g003}

In-Frame Deletion of *hem* in *V*. *alginolyticus* {#sec006}
--------------------------------------------------

To test the feasibility of our strategy for gene knockout in *Vibrio* species, the *hem* gene (coding hemolysin) from *V*. *alginolyticus* E0601 was first selected as a target gene ([Fig 4](#pone.0144465.g004){ref-type="fig"}). Both suicide T-vectors pLP11-T and pLP12-T were used for *hem* knockout. The result showed that both pLP11-*hem* and pLP12-*hem* could integrate into a chromosomal site to form insertional mutants as PCR tests using an external primer *hem*-TF (anchoring upstream of integration site) and an internal primer pLP-UR (anchoring one vector-specific region) revealed that insertional mutants generated one predicted 946-bp band while wild-type E0601 could not as pLP-UR failed match any sites of genomic DNAs from E0601 (only the results from the pLP11-based knockout were shown in [Fig 5](#pone.0144465.g005){ref-type="fig"}, as both plasmids aimed at the same gene and led to an identical result). After counterselection driven by toxicity of Vmi480, both suicide vectors could lead to the generation of deletion mutants, as deletion mutants gave rise to one truncated PCR band (1141 bp) while wild-type E0601 gave rise to a normal PCR band (1699 bp) when using two external primers respectively targeting upstream and downstream of *hem* gene ([Fig 4](#pone.0144465.g004){ref-type="fig"}). The sequencing of PCR products also confirmed that insertion and deletion mutants were successfully obtained. In the counterselection step, 16 colonies resulting from strain LP204 (integrated pLP11-*hem*) and strain LP206 (integrated pLP12-*hem*) were randomly selected for a PCR test; 3 and 12 colonies were confirmed to be the deletion mutants of the *hem* gene. A higher occurrence of deletion mutants was observed when using the pLP12 plasmid.

![Schematic diagram of wild type, insertional mutation and deletion mutation of targeted genes.\
Targeted genes are shown with light gray arrows and their adjacent genes are shown with black arrows. Black triangles represent annealing sites of external or internal primers. The gene names prefixed with "T-" represent the names of the truncated genes.](pone.0144465.g004){#pone.0144465.g004}

![PCR confirmation of insertional disruption and deletion of six genes in four *Vibrio* species.\
(A) Lane M: DNA marker DL2000; lanes 1--3: PCRs using primers *hem*-TF/pLP-UR to test wild type, insertional disruption and negative control (water as a template) of *hem* in *V*. *alginolyticus* E0601; lanes 4--6: PCRs using primers *hem*-TF/*hem*-TR to test wild type, deletion mutant and negative control (water as a template) of *hem* in *V*. *alginolyticus* E0601 (PCR tests for insertional disruption and deletion of *hem* using pLP11 and pLP12 had the same results, so only the results from pLP11 were shown); lanes 7--9: PCRs using primers *degS*-TF/pLP-UR to test wild type, insertional disruption and negative control (water as a template) of *degS* in *V*. *cholerae* HN375; lanes 10--12: PCRs using primers *degS*-TF/*degS*-TR to test wild type, deletion mutant and negative control (water as a template) of *degS* in *V*. *cholerae* HN375; lanes 13--15: PCRs using primers *vasC*-TF/pLP-UR to test wild type, insertional disruption and negative control (water as a template) of *vasC* in *V*. *cholerae* HN375; lanes 16--18: PCRs using primers *vasC*-TF/*vasC*-TR to test wild type, deletion mutant and negative control (water as a template) of *vasC* in *V*. *cholerae* HN375. (B) Lane M: DNA marker DL2000; lanes 1--3: PCRs using primers *impB*-TF/pLP-UR to test wild type, insertional disruption and negative control (water as a template) of *impB* in *V*. *vulnificus* ATCC 27562; lanes 4--6: PCRs using primers *impB*-TF/*impB*-TR to test wild type, deletion mutant and negative control (water as a template) of *impB* in *V*. *vulnificus* ATCC 27562; lanes 7--9: PCRs using primers *ascS*-TF/pLP-UR to test wild type, insertional disruption and negative control (water as a template) of *ascS* in *V*. *parahaemolyticus* E06135; lanes 10--12: PCRs using primers *ascS*-TF/*ascS*-TR to test wild type, deletion mutant and negative control (water as a template) of *ascS* in *V*. *parahaemolyticus* E06135; lanes 13--15: PCRs using primers *pilO*-TF/pLP-UR to test wild type, insertional disruption and negative control (water as a template) of *pilO* in *V*. *parahaemolyticus* E0680; lanes 16--18: PCRs using primers *pilO*-TF/*pilO*-TR to test wild type, deletion mutant and negative control (water as a template) of *pilO* in *V*. *parahaemolyticus* E0680.](pone.0144465.g005){#pone.0144465.g005}

In-Frame Deletion of *degS* and *vasC* in *V*. *cholerae* {#sec007}
---------------------------------------------------------

To test the feasibility of the genetic tool for gene knockout in *V*. *cholerae*, pLP12-T was used for deletion mutation of *degS* (coding periplasmic serine peptidase) and *vasC* (coding uncharacterized protein in type VI secretion system) in *V*. *cholerae* HN375 ([Fig 4](#pone.0144465.g004){ref-type="fig"}). As shown in [Fig 5](#pone.0144465.g005){ref-type="fig"}, pLP12-*degS* was integrated into the chromosome, as it led to a 1047-bp PCR fragment when using an external primer *degS*-TF (anchoring upstream of integration site) and the internal vector-specific primer pLP-UR. However, wild-type HN375 could not produce any band when using the same primer pair due to the lack of annealing site by the primer pLP-UR. Under counterselection pressure, the integrated plasmid was removed through a second homologous recombination to form the deletion mutant, which produced a short 1126-bp PCR fragment in the deletion mutant while the wild-type strain HN375 only resulted in a normal band with a size of 1696 bp when using two external primers *degS*-TF/*degS*-TR. As expected, the insertional mutant of *vasC* generated by pLP12-*vasC* led to a 1224-bp PCR fragment but the wild-type strain HN375 could not. The deletion mutant of *vasC* led to a short 1226-bp PCR product while wild-type strain HN375 only generated a normal 1931-bp band. Insertional and deletion mutants of *degS* and *vasC* were also confirmed by subsequent sequencing of PCR products. In the counterselection step, 16 colonies resulting from integrated pLP12-*degS* or pLP12-*vasC* were randomly selected for a PCR test; 8 and 7 colonies were confirmed to be the deletion mutants for *degS* and *vasC*, respectively.

In-Frame Deletion of *pilO* and *ascS* in *V*. *parahaemolyticus* {#sec008}
-----------------------------------------------------------------

pLP12-T was also used for deletion mutation of *pilO* (coding type IV pilus biogenesis protein) and *ascS* (coding preprotein translocase S) in *V*. *parahaemolyticus* ([Fig 4](#pone.0144465.g004){ref-type="fig"}). To verify that the method can be used in different strains of the same *Vibrio* species, we aimed to delete *pilO* in *V*. *parahaemolyticus* E0680 and *ascS* in *V*. *parahaemolyticus* E06135. As shown in [Fig 5](#pone.0144465.g005){ref-type="fig"}, the result revealed that pLP12-*pilO* integrated into the chromosomal site of E0680 to generate a 1062-bp PCR fragment as expected, while the wild-type strain didn't result in an amplicon when using primers *pilO*-TF and pLP-UR. After counterselection, the integrated plasmid was removed through a second homologous recombination, and it generated a short 835-bp PCR product representing in-frame deletion. Compared with deletion mutants, wild-type E0680 gave rise to a normal PCR product of 1491 bp when using the same primer pair. Knockout of *ascS* in E06135 had the same outcome. An insertional mutant of *ascS* resulted in one 835-bp PCR fragment and an deletion mutant of the gene resulted in truncated PCR fragment of 1108 bp compared with a normal PCR fragment of 1357 bp from the wild-type strain. PCR results were confirmed by the following sequencing. In the counterselection step, 16 colonies resulting from LP246 (integrated pLP12-*pilO*) or LP248 (integrated pLP12-*ascS*) were randomly selected for a PCR test; 7 and 3 colonies were confirmed to be the deletion mutants of *pilO* and *ascS*, respectively.

In-Frame Deletion of *impB* in *V*. *vulnificus* {#sec009}
------------------------------------------------

To test the feasibility of the genetic tool for gene knockout in *V*. *vulnificus*, *impB* (coding uncharacterized protein in type VI secretion system) in *V*. *vulnificus* ATCC 27562 was selected as target gene ([Fig 4](#pone.0144465.g004){ref-type="fig"}). As shown in [Fig 5](#pone.0144465.g005){ref-type="fig"}, pLP12-*impB* integrated into the desired chromosomal site to generate a 1061-bp PCR fragment, while the wild-type strain didn't. After counterselection, PCR for the clone representing the deletion mutant generated a short 1045-bp DNA fragment as expected, while the wild-type strain generated a normal 1426-bp DNA fragment when using the same external primer pair. The PCR results were confirmed by the following sequencing. In the counterselection step, 20 colonies were randomly selected for a PCR test; 6 colonies resulting from integrated pLP12-*impB* were confirmed to be the deletion mutants. Thus, the results demonstrated that deletion of *impB* was successfully achieved.

Discussion {#sec010}
==========

Though there are several successful cases of using *sacB*-based suicide vectors for gene knockout in *Vibrio* \[e.g., 16--19\], SacB toxicity is susceptible to the presence of NaCl in the selective medium \[[@pone.0144465.ref026]\], while the addition of NaCl to the media is absolutely necessary for the growth of nearly all *Vibrio* species \[[@pone.0144465.ref027]\].The inadequate toxicity of SacB must largely decrease the occurrence ratio of the correct deletion mutants on counterselective plates, which inevitably increases the difficulty of screening. Therefore, the lack of a suitable counterselective marker has actually become a primary obstacle to genetic manipulation in *Vibrio*. In 2007, Roux et al. constructed a deletion mutant of the *vsm* gene in *V*. *splendidus* by using a *ccdB*-based suicide vector \[[@pone.0144465.ref012]\]; that study shed some light on the application of a new counterselective marker in the genetic manipulation of *Vibrio* species. However, there is still concern about whether CcdB originated from the F plasmid of *E*. *coli*, which has extensive and strong toxicity in many other *Vibrio* species because CcdB poisons GyrA (the subunit of DNA gyrase) by forming a binding complex \[[@pone.0144465.ref028]\] while GyrA proteins from *Vibrio* are only distantly related with those from *E*. *coli* strains (comparison by Blastp). In the discrepant intracelluar environment of *Vibrio* (halophilic bacteria), the affinity of CcdB to GyrA in *Vibrio* is likely not as strong as it is in *E*. *coli*. In light of these facts and considerations, exploring new alternative marker genes from rare *Vibrio* strains could help develop genetic tools for gene knockout in *Vibrio*.

First, we aimed to explore the function of *vmi480* and *vmi470* because a Blastx search suggested that *vmi470* codes a DNA-binding protein and its orthologous proteins includes several transcription factors. Thus, we doubted whether *vmi470* plays an important role in the genomic island, MGI*Vmi*1. In another aspect, *vmi480* and *vmi470* constitute an operon with their own promoter and their genetic configuration resemble those of most type II TA systems \[[@pone.0144465.ref023], [@pone.0144465.ref024]\], and thus it also raised a question whether they represent a TA module. In most cases for identification of new TA pairs, gene deletion mutation *in vivo* and ectopic expression of TA genes are key procedures besides theoretical prediction \[[@pone.0144465.ref024],[@pone.0144465.ref029]\]. In our case, the attempt to construct a null mutant of a single *vmi470* failed, while deletion of *vmi480* and deletion of *vmi470* and adjacent *vmi480* together were easily achieved. The features of the conserved domains of *vmi470* are similar to antitoxins CcdA and ParD because both of them have a DNA-binding domain at their N-terminal region and have a catalytic domain at their C-terminal region that reacts with their toxins, CcdB and ParE, respectively \[[@pone.0144465.ref030]--[@pone.0144465.ref032]\]. This suggests that *vmi480* and *vmi470* probably serve as a TA system. Sole expression of *vmi480* was lethal to the cells but the lethal effect could be eliminated when *vmi480* and *vmi470* were co-expressed in the same vector. It clearly showed that the product of *vmi470* serves as an antidote of Vmi480. Generally, co-expression of toxin and antitoxin gene is achieved through adopting two compatible vectors and using different inducers \[[@pone.0144465.ref033]--[@pone.0144465.ref035]\]. But in our case, we take the full advantages of the genetic structure that not only *vmi480* and *vmi470* are tightly linked (only a 5-bp intergenic region) but also candidate toxin gene *vmi480* locates upstream of candidate antitoxin *vmi470*. It ensures that both genes can be expressed in one expression vector. Suppose that the downstream *vmi470* in the same transcription unit cannot be expressed, Vmi480 will kill cells without the participation of Vmi470. Compared with most of type IITA system, *vmi480*-*vmi470* exhibits two distinct characteristics. One is that candidate toxin consisting of 198 amino acids is encoded by the first gene; this organization is opposite to the widespread TA gene order but occurs in several TA systems such as *higBA* \[[@pone.0144465.ref029],[@pone.0144465.ref035]\], *hicAB* \[[@pone.0144465.ref036]\] and *mqsR*-*ygiT* \[[@pone.0144465.ref024]\]. Another is that *vmi470* code a candidate antitoxin with a big size of 362 amino acids. Generally, toxin and antitoxin have the small sizes (31--204 amino acids for antitoxins and 41--206 amino acids for toxins) \[[@pone.0144465.ref023]\]. However, *vmi470* is not the only exception: gene VC0815 from a TA system of *V*. *cholerae* even codes a toxin with much bigger size of 453 amino acids \[[@pone.0144465.ref034]\]. All these results and analysis well support the idea that *vmi480* and *vmi470* compose a new TA system. These findings actually diversify the TA families and expand our knowledge on TA systems.

Vmi480 exhibited a strong lethal effect to *E*. *coli* cells, and it suggests that although this toxin originates from *Vibrio*, it may have toxicity to bacterial cells from extensive sources. In another aspect, *vmi480* and *vmi470* only exist in rare *Vibrio* strains, which guarantee that *vmi480* is suitable as a counterselection marker for gene deletion in *Vibrio* in most cases. These features of *vmi480* and its product Vmi480 suggest that the *vmi480* gene can be used as an ideal counterselection marker, especially in the construction of suicide vectors. Gaining insight into the mechanism of *vmi480* and *vmi470* is currently ongoing.

Consequently, we constructed suicide vectors based on the plasmid pSW23T and the toxin gene *vmi480* and attempted to use them in the deletion mutation in *Vibrio* strains. *V*. *cholerae*, *V*. *parahaemolyticus* and *V*. *vulnificus* were selected because they are the most harmful *Vibrio* pathogens to humans \[[@pone.0144465.ref004]\]; thus, there is a more urgent need to develop convenient tools for their genetic manipulation. On the other hand, *V*. *alginolyticus* widely distributes in estuary and marine environments \[[@pone.0144465.ref037],[@pone.0144465.ref038]\], and this bacterium has garnered increased concern, as some strains have been reported as pathogenetic to aquatic animals and have caused huge economic losses \[[@pone.0144465.ref004],[@pone.0144465.ref037],[@pone.0144465.ref039]\]. Therefore, *V*. *alginolyticus* was also selected as a desired target for attempted gene knockout. We easily obtained six deletion mutants in five strains from these *Vibrio* species by using new suicide plasmids, pLP11 and pLP12, and the highly efficient conjugation system developed by Demarre et al. \[[@pone.0144465.ref021]\]. In this conjugation system, donor strain *E*. *coli* β2163 not only contains the transfer apparatus to drive suicide plasmids but also cannot grow on LB plates without thymidine and diaminopimelic acid (DAP) \[[@pone.0144465.ref021]\]. Therefore, it can minimize the sizes of suicide plasmids and does not require selective markers from the recipient cells \[[@pone.0144465.ref021]\]. By using this conjugation system coupled with pSW27, *V*. *cholerae* suicide transconjugants were obtained with an overall conjugation--recombination frequency of approximately 2× 10^−7^ transconjugants per recipient \[[@pone.0144465.ref021]\]. In our experiments, we could obtain 30--70 colonies (suicide transconjugants) on each plate (10^0^ dilution) every time in the first selection (data not shown), which was sufficient to perform the following counterselection. Furthermore, in the counterselection step, we could obtain 3--12 positive colonies (deletion mutants) by randomly screening no more than 20 colonies. The high occurrence of deletion mutants is primarily due to the expression of *vmi480* under induction conditions. As a result, the application of *vmi480* actually saves time for the screening of deletion mutants.

In the conventional strategies of gene deletion through suicide vectors, PCR products and suicide vectors are generally digested by the same restriction enzymes and are then purified before ligation. Occasionally, altering the cloning sites must be performed due to the difference in sequences of inserted DNA fragments. Therefore, the operations are somewhat laborious. To overcome these flaws, we introduced double *Ahd*I sites in MCS and digested pLP11 and pLP12 with *Ahd*I to generate suicide T-vectors. This strategy does not require consideration of restriction sites and evades the laborious steps of digestion and the following purification. In this strategy, purified PCR products are directly ligated with linearized suicide T-vectors. Once linearized suicide T-vectors are prepared, they can be stored and used repeatedly. Therefore, this accelerates the process of gene knockout based on suicide vectors. We do not need to consider the insertional orientation of allelic DNA fragments in suicide vectors because no matter how they are inserted, the suicide vectors carrying allelic DNA fragments will integrate into the desired chromosomal sites in the correct direction due to the homologous recombination mechanism, which will not influence the function of suicide vectors. Of course, we still retain MCS sites in two vectors to meet the preference of different users.

The expression of target genes under the tight control of the P~BAD~ promoter from *E*. *coli* is induced by L-arabinose \[[@pone.0144465.ref040]\]. To date, the P~BAD~ promoter expression system has been used in many Gram-negative bacteria, such as *E*. *coli*, *Salmonella typhimurium* and *Xanthomonas* sp. \[[@pone.0144465.ref041]\]. P~BAD~-based suicide vectors or expression vectors were also successfully used in some *Vibrio* species \[[@pone.0144465.ref012],[@pone.0144465.ref042]--[@pone.0144465.ref044]\], which suggested that the permeability of L-arabinose may not be a problem in *Vibrio* species. However, there are few reports that P~TAC~-based suicide vectors or expression vectors are used in *Vibrio* cells. Furthermore, the low permeability of isopropyl β-D-1-thiogalactopyranoside (IPTG) has been observed in *Corynebacterium glutamicum* strains, which hampers the application of a P~TAC~-based induction system in this bacterium \[[@pone.0144465.ref041]\]. It is well known that IPTG acts as an analogue of lactose in expression systems based on the *lac* operon; lactose is mainly transported through lactose permease on the cell membrane of *E*. *coli* \[[@pone.0144465.ref045],[@pone.0144465.ref046]\]. However, no lactose permease has been discovered in *Vibrio* to date. This suggests that induction from IPTG in *Vibrio* may not be as efficient as induction in *E*. *coli*. In our case, the loss of integrated pLP11 was not observed in *V*. *alginolyticus* when using 1 mM of IPTG (usual dosage for induction) to induce the expression of *vmi480* (data not shown) until we increased the dosage of IPTG to 5 mM. Given these considerations, although we successfully developed two suicide plasmids carrying *vmi480* and different promoter systems, we prefer to use the suicide plasmid pLP12 containing the P~BAD~ promoter activated by L-arabinose.

Finally, we must note that although our genetic tools were designed to be used in gene disruption in *Vibrio*, they likely have the potential to be applied in other Gram-negative bacteria because the toxicity of Vmi480 may be broad-spectrum to various bacteria and donor strain *E*. *coli* β2163 can conjugate with a wide range of Gram-negative bacteria \[[@pone.0144465.ref021]\].

Conclusions {#sec011}
===========

In this study, we confirmed that *vmi480* and *vmi470* in a genomic island, MGI*Vmi*1, from *V*. *mimicus* VM573 belong to a type of two-component toxin-antitoxin system through their knockout and expression. *vmi480* is an uncharacterized toxin gene. We constructed two suicide T-vectors featuring the toxin gene *vmi480*, a P~BAD~ or P~TAC~ promoter system, and a MCS region including two *Ahd*I sites. Linearized vectors by *Ahd*I digestion can be stored and directly ligated with purified PCR products without digestion steps. Using two suicide T-vectors coupled with a highly efficient conjugation system from *E*. *coli* β2163, we easily deleted six genes from four representative *Vibrio* species. Through the use of counterselective marker *vmi480*, we could obtain 3--12 positive colonies (deletion mutants) among no more than 20 randomly selected colonies on counterselection plates. These results demonstrated that we successfully developed universal genetic tools for rapid and efficient gene deletion in *Vibrio* species.

Materials and Methods {#sec012}
=====================

Bacterial Strains, Plasmids, and Culture Conditions {#sec013}
---------------------------------------------------

The bacterial strains and plasmids used in this study are listed in [Table 2](#pone.0144465.t002){ref-type="table"}. *E*. *coli* and *Vibrio* strains were cultured in LB medium. DAP were supplemented to a final concentration of 0.3 mM when necessary. Antibiotics were used at the following concentrations: nalidixic acid (Nx), 40 μg/ml; ampicillin (Ap), 100 μg/ml; spectinomycin (Sp), 50 μg/ml; kanamycin (Kn), 50μg/ml; chloramphenicol (Cm), 20 μg/ml for the propagation of suicide plasmids in host strains, and 10 μg/ml for integrated plasmids in *Vibrio* genomes. Induction of gene expression under the control of the P~BAD~ promoter (from pBAD30 or pLP12) was achieved by the addition of 0.2% L-arabinose to the growth media, and the expression was repressed by the addition of 0.3% D-glucose. Induction of *vmi480* expression under control of the P~TAC~ promoter was carried out by the addition of IPTG to the LB plates at a final concentration of 5 mM.

10.1371/journal.pone.0144465.t002

###### Strains and plasmids used in this study.

![](pone.0144465.t002){#pone.0144465.t002g}

  Strain or plasmid         Description                                                                                                    Reference or source
  ------------------------- -------------------------------------------------------------------------------------------------------------- ----------------------------
  *E*. *coli*                                                                                                                              
      DH5α λ*pir*           F^−^ φ80 *lacZ* Δ*M15 recA1 end A1 hsdR17 supE44 thi-1 gyrA96 relA1* (*lacZYA*-*argF*) *U169* λ*pir* lysogen   Laboratory collection
      NEB5α                                                                                                                                NEB
      β2163                 (F-) RP4-2-Tc::Mu Δ*dapA*::(*erm*-*pir*)                                                                       \[[@pone.0144465.ref021]\]
      LP79                  MG1655 MGI*Vmi*1 *res2*::pSW23T (Nx^R^, Cm^R^)                                                                 \[[@pone.0144465.ref022]\]
      LP86                  MG1655 MGI*Vmi*1 *res2*::pSW23T pKD46 (Nx^R^, Cm^R^, Ap^R^)                                                    This study
      LP116                 MG1655 MGI*Vmi*1 *res2*::pSW23T Δ*vmi480*-*470* (Nx^R^, Cm^R^)                                                 This study
      LP128                 MG1655 MGI*Vmi*1 *res2*::pSW23T Δ*vmi480* (Nx^R^, Cm^R^)                                                       This study
      LP134                 NEB5α pBAD30-*vmi480*-*470* (Ap^R^)                                                                            This study
      LP135                 NEB5α pBAD30-*vmi470* (Ap^R^)                                                                                  This study
      LP192                 NEB5α pBAD30-*vmi480* (Ap^R^)                                                                                  This study
      LP194                 DH5α λpir pLP10 (Cm^R^)                                                                                        This study
      LP196                 DH5α λpir pLP11 (Cm^R^)                                                                                        This study
      LP197                 DH5α λpir pLP12 (Cm^R^)                                                                                        This study
  *V*. *alginolyticus*                                                                                                                     
      E0601                 Isolated from seawater in Yangjiang, China                                                                     This study
      LP204                 E0601 *hem*::pLP11 (Cm^R^)                                                                                     This study
      LP206                 E0601 *hem*::pLP12 (Cm^R^)                                                                                     This study
      LP207                 E0601 Δ*hem* (resulted from LP204)                                                                             This study
      LP208                 E0601 Δ*hem* (resulted from LP206)                                                                             This study
  *V*. *cholerae*                                                                                                                          
      HN375                 Isolated from seawater in Zhanjiang, China                                                                     This study
      LP228                 HN375 *degS*::pLP12 (Cm^R^)                                                                                    This study
      LP233                 HN375 Δ*degS*                                                                                                  This study
      LP230                 HN375 *vasC*::pLP12 (Cm^R^)                                                                                    This study
      LP235                 HN375 Δ*vasC*                                                                                                  This study
  *V*. *parahaemolyticus*                                                                                                                  This study
      E0680                 Isolated from an oyster in Yangjiang, China                                                                    This study
      E06135                Isolated from *Litopenaeus vannamei* in Yangjiang, China                                                       This study
      LP246                 E0680 *pilO*:: pLP12 (Cm^R^)                                                                                   This study
      LP250                 E0680 Δ*pilO*                                                                                                  This study
      LP248                 E06135 *ascS*:: pLP12 (Cm^R^)                                                                                  This study
      LP252                 E06135 Δ*ascS*                                                                                                 This study
  *V*. *vulnificus*                                                                                                                        This study
      ATCC 27562                                                                                                                           ATCC
      LP239                 ATCC 27562 *impB*:: pLP12 (Cm^R^)                                                                              This study
      LP244                 ATCC 27562 Δ*impB*                                                                                             This study
  Plasmids                                                                                                                                 
      pSW23T                *oriT* ~RP4~ *oriV* ~R6K~ (Cm^R^)                                                                              \[[@pone.0144465.ref021]\]
      pSW25T-*ccdB*         *oriT* ~RP4~ *oriV* ~R6K~ *ccdB* (Sp^R^)                                                                       Laboratory collection
      pBAD30                *ori* ~p15A~ *araC* P~BAD~ (Ap^R^)                                                                             \[[@pone.0144465.ref040]\]
      pKD4                  PCR template for one-step gene inactivation (Kn^R^)                                                            \[[@pone.0144465.ref025]\]
      pKD13                 PCR template for one-step gene inactivation (Kn^R^)                                                            \[[@pone.0144465.ref025]\]
      pKD46                 λ- recombination plasmid (Ap^R^)                                                                               \[[@pone.0144465.ref025]\]
      pCP20                 Helper plasmid to delete resistant gene with FRT sites (Ap^R^)                                                 \[[@pone.0144465.ref025]\]
      pLP10                 *oriT* ~RP4~ *oriV* ~R6K~ *ccdB* P~TAC~ promoter (Cm^R^)                                                       This study
      pLP11                 *oriT* ~RP4~ *oriV* ~R6K~ *vmi480* P~TAC~ promoter (Cm^R^)                                                     This study
      pLP12                 *oriT* ~RP4~ *oriV* ~R6K~ *vmi480* P~BAD~ (Cm^R^)                                                              This study
      pLP11-*hem*           pLP11 containing homologous arms of *hem* gene of E0601                                                        This study
      pLP12-*hem*           pLP12 containing homologous arms of *hem* gene of E0601                                                        This study
      pLP12-*degS*          pLP12 containing homologous arms of *degS* gene of HN375                                                       This study
      pLP12-*vasC*          pLP12 containing homologous arms of *vasC* gene of HN375                                                       This study
      pLP12-*pilO*          pLP12 containing homologous arms of *pilO* gene of E0680                                                       This study
      pLP12-*ascS*          pLP12 containing homologous arms of *ascS* gene of E06135                                                      This study
      pLP12-*impB*          pLP12 containing homologous arms of *impB* gene of ATCC 27562                                                  This study

PCR, Sequencing and Other Molecular Methods {#sec014}
-------------------------------------------

PCR assays were performed using the primers described in [S1 Table](#pone.0144465.s001){ref-type="supplementary-material"}. When PrimSTAR Max DNA Polymerase (Takara, China) was used, PCR conditions were as follows: 2 min at 98°C; 30 cycles of 10 sec at 98°C, 10 sec at the appropriate annealing temperature, 30 sec/kb at 72°C; and 5 min at 72°C. When rTaq DNA Polymerase (Takara) was used, PCR conditions were as follows: 4 min at 94°C; 30 cycles of 20 sec at 94°C, 30 sec at the appropriate annealing temperature, 1 min/kb at 72°C; and 7 min at 72°C. When necessary, PCR products were purified using a DNA Purification and Concentration Kit (ZhongDing, China). When necessary, PCR products were also sent to the company (BGI, China) for direct sequencing. Plasmids were extracted using the PureYield Plasmid Miniprep System (Promega, USA) according to the manufacturer's instruction.

Construction of Null Mutants for *vmi480*, *vmi470* and *vmi480-470* in *E*. *coli* {#sec015}
-----------------------------------------------------------------------------------

*E*. *coli* LP79 was first transformed with the recombination plasmid pKD46 by electroporation according to Dower et al. \[[@pone.0144465.ref047]\]. Electroporation was carried out in a BioRad Gene Pulser Xcell apparatus set at 25 μF and 1.8 kV using 1-mm gap electroporation cuvettes. One-step inactivations of *vmi480*, *vmi470*, and *vmi480*-*470* in the transformant LP86 (carrying pKD46) were carried out with the protocol from Datsenko et al. \[[@pone.0144465.ref025]\]. pKD4 and pKD13 were used to generate PCR fragments containing homologous arms of the abovementioned genes and a kanamycin-resistant cassette.

Construction of Expression Vectors of *vmi480*, *vmi470* and *vmi480*-*470* {#sec016}
---------------------------------------------------------------------------

Complete genes of *vmi480*, *vmi470* and *vmi480*-*470* were amplified by primer pairs, 480-exF/480-exR, 470-exF/470-exR and 480-470-exF/480-470-exR, respectively. PCR products of *vmi480*, *vmi470* and *vmi480*-*470* were purified and digested with *Eco*R I and *Xba* I, and they were ligated with vector pBAD30 digested with the same restriction enzymes. The ligation products were transformed into competent *E*. *coli* NEB5a cells (NEB) according to the manufacturer's instructions. During the construction of the transformant hosting the plasmid pBAD30-*vmi480*, D-glucose was added into the medium to repress expression of *vmi480*. Transformants were screened on LB plates supplemented with Ap. Transformants were identified by PCR using the primer pair pBAD30-TF/pBAD30-TR and were confirmed by subsequent sequencing.

Assay of the Lethal Effect of Toxin Vmi480 and Its Antidote Vmi470 {#sec017}
------------------------------------------------------------------

To test the lethal effect of Vmi480 and the antagonism of Vmi470 against Vmi480, transformants of *E*. *coli* LP134 (pBAD30-*vmi480*-*470*), LP135 (pBAD30-*vmi470*) and LP192 (pBAD30-*vmi480*) were grown in LB broth supplemented with D-glucose at 37°C for 6 hr and serially diluted. Samples (10^−4^ dilution) were spread on LB plates with D-glucose or with L-arabinose, and they were then incubated at 37 C overnight.

Construction of Suicide T-Vectors carrying the Lethal Gene *vmi480* {#sec018}
-------------------------------------------------------------------

In the process of constructing suicide T-vectors, pSW23T and pSW25T-*ccdB* were used as the initiator plasmids. PCR of pSW23T was carried out using the primer pair pSW23T-F/pSW23T-R to generate a fragment containing *oriV* ~R6Kγ~, *oriT* ~RP4~ and *cat*. PCR of pSW25T-*ccdB* was carried out using the primer pair pSW25T-F/pSW25T-R to generate a fragment containing *ccdB*, *lacIq* and P~TAC~. A multiple cloning site (*Ahd*I-*Eco*RI-*Sac*I-*Ahd*I-*Nhe*I) was introduced by primers pSW23T-F and pSW25T-F. Two fragments were purified, digested by *Eco*RI and *Sph*I, and ligated together. The ligation product was transformed into *E*. *coli* DH5α λ pir cells to obtain a strain LP194 hosting a resultant plasmid, pLP10. Chemical transformations were performed according to the method by Swords \[[@pone.0144465.ref048]\]. The construction of pLP10 was tested by PCR with two primer pairs, pLP10L-TF1/ pLP10L-TR1 and pLP10L-TF2/ pLP10L-TR2, and confirmed by sequencing.

A fragment containing all the parts of pLP10 except *ccdB* was acquired by reverse PCR amplification from pLP10 using primers pLP10-F and pLP10-R. *vmi480* was amplified from *E*. *coli* LP79 using primers *vmi480*-F and *vmi480*-R. They were purified, digested by *Nde*I and *Xho*I, and ligated together, and then the ligation product was transformed into *E*. *coli* DH5α λ pir cells to obtain a strain LP196 hosting a resultant plasmid, pLP11. The construction of pLP11 was confirmed by the primer pair pLP11L-TF/pLP11L-TR followed by sequencing.

pLP11 was amplified with primers pLP11-F and pLP11-R to generate a fragment retaining all the parts of the plasmid except the P~TAC~ promoter and *lacIq* gene. The P~BAD~ promoter system was amplified from plasmid pBAD30 using primers pBAD30-PF and pBAD30-PR. Two fragments were recombined together through *in vitro* recombination using ClonExpress® II One Step Cloning Kit (Vazyme, China), where recombinase Exnase was used to avoid the excess introduction of restriction sites into the resulting plasmid. The recombination product was transformed into *E*. *coli* DH5α λ pir cells to obtain a strain LP197 hosting the resultant plasmid, pLP12. The construction of pLP12 was confirmed by PCR testing with the primer pair pLP12L-TF/pLP12L-TR followed by sequencing.

To avoid repetitive extraction of plasmids for generating suicide T-vectors and to decrease the false clones in the subsequent construction of recombinant T-vectors, pLP11 and pLP12 were amplified using PrimSTAR Max DNA Polymerase and the primer pair STVU-F/STVU-R. PCR products were digested by *Ahd*I and purified to finally obtain the linearized suicide T-vectors pLP11-T and pLP12-T.

Construction of Deletion Mutants of Six Genes from Four *Vibrio* Species {#sec019}
------------------------------------------------------------------------

Six genes from four representative *Vibrio* species were targeted for deletion mutation. In-frame deletion fragments consisting of two flanking regions of each target locus were made by overlap extension PCR \[[@pone.0144465.ref019]\]. PrimSTAR Max DNA Polymerase was adopted in the first PCR, and rTaq DNA polymerase was used in the second PCR to conveniently add the single base A to the 3\' end of the PCR products. The final PCR products were purified and ligated with pLP11-T or pLP12-T. The ligation products were transformed into competent *E*. *coli* DH5α λ pir cells to generate recombinant suicide plasmids carrying these homologous fragments for allelic exchange of targeted genes. Recombinant plasmids were extracted and transformed into *E*. *coli* β2163 by electroporation. Then, the recombinant plasmids were transferred into *Vibrio* strains through conjugation.

Conjugations were performed by mixing equal volumes of recombinant *E*. *coli* β2163 and each *Vibrio* strain grown overnight at 37°C. The cells were harvested by centrifugation for 2 min at 8000 g, washed in 400 μL of LB broth and resuspended in 10 μL of LB broth. Mating mixtures were then deposited on LB plates supplemented with DAP and D-glucose and incubated at 37°C for 8 hr. The cells were recovered from the plates in 1 ml of LB broth. Each of the 100-μL of mixed cells was spread on LB plates supplemented with Cm and D-glucose for screening of single-crossover cells with integrated plasmids into specific chromosomal loci. The clones were purified on the same LB plates to make sure that stable and correct insertional mutants were obtained. Then, these insertional mutants were checked by PCR with external primers targeting upstream of integration sites and an internal primer targeting vector-specific region. In this condition, wild-type strains will not result in any predicted PCR bands. Insertional mutants were grown at 37°C for 6 hr, serially diluted, and spread on LB plates supplemented with IPTG or L-arabinose for counterselection of deletion mutants (double-crossover recombination). The clones on counterselection plates were randomly selected and purified before PCR assays. Two external primers respectively anchoring upstream and downstream of targeted genes were adopted for the detection of deletion mutants. All of the insertional mutants and deletion mutants were confirmed by PCR using the same primer pair and subsequent sequencing.

Bioinformatics Analysis and Nucleotide Sequence Accession Numbers {#sec020}
-----------------------------------------------------------------

Blastx searches against *vmi480* and its adjacent *vmi470* were performed to predict their function. The promoter was predicted by online tools (<http://molbiol-tools.ca/Promoters.htm>). A web-based TA prediction tool was adopted to identify *vmi480* and *vmi470* (<http://genoweb1.irisa.fr/duals/RASTA-Bacteria/index.php?page=form>). The sequences of the suicide plasmids pLP11 and pLP12 have been deposited at GenBank under accession numbers KT326152 and KT326153, respectively.

Supporting Information {#sec021}
======================
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